ZA200806411B - Stabilized pharmaceutical compositions comprising fesoterodine - Google Patents

Stabilized pharmaceutical compositions comprising fesoterodine

Info

Publication number: ZA200806411B
Authority: ZA; South Africa
Prior art keywords: fesoterodine; pharmaceutical compositions; stabilized pharmaceutical; stabilized; compositions
Prior art date: 2006-06-09

Application number

ZA200806411A

Other languages

English (en)

Inventor

Arth Christoph

Mika Hans-Juergen

Komenda Michael

Lindner Hans

Bicane Fatima

Paulus Kerstin

Irngartinger Meike

Original Assignee

Sanol Arznei Schwarz Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-06-09

Filing date

2008-07-21

Publication date

2009-05-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38521333&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200806411(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-07-21 Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh

2009-05-27 Publication of ZA200806411B publication Critical patent/ZA200806411B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biophysics (AREA)
Emergency Medicine (AREA)
Molecular Biology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Urology & Nephrology (AREA)
Inorganic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

ZA200806411A 2006-06-09 2008-07-21 Stabilized pharmaceutical compositions comprising fesoterodine ZA200806411B (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP06011942		2006-06-09
EP06011943		2006-06-09
EP06011941		2006-06-09

Publications (1)

Publication Number	Publication Date
ZA200806411B true ZA200806411B (en)	2009-05-27

Family

ID=38521333

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200806411A ZA200806411B (en)	2006-06-09	2008-07-21	Stabilized pharmaceutical compositions comprising fesoterodine

Country Status (37)

Country	Link
EP (1)	EP2029134B1 (xx)
JP (2)	JP4743321B2 (xx)
KR (1)	KR101316773B1 (xx)
CN (1)	CN101466371B (xx)
AP (1)	AP2416A (xx)
AR (1)	AR061289A1 (xx)
AT (1)	ATE517619T1 (xx)
AU (1)	AU2007255408B2 (xx)
BR (1)	BRPI0712865B1 (xx)
CA (1)	CA2652712C (xx)
CR (1)	CR10494A (xx)
CU (1)	CU23850B1 (xx)
CY (1)	CY1111934T1 (xx)
DK (1)	DK2029134T3 (xx)
EA (1)	EA015909B9 (xx)
EC (1)	ECSP089010A (xx)
ES (1)	ES2370943T3 (xx)
GT (1)	GT200800276A (xx)
HR (1)	HRP20110776T1 (xx)
IL (2)	IL195732A (xx)
MA (1)	MA30504B1 (xx)
MX (1)	MX2008015736A (xx)
MY (1)	MY146574A (xx)
NI (1)	NI200800318A (xx)
NL (1)	NL2000690C2 (xx)
NO (1)	NO341980B1 (xx)
NZ (1)	NZ572616A (xx)
PE (2)	PE20080331A1 (xx)
PL (1)	PL2029134T3 (xx)
PT (1)	PT2029134E (xx)
RS (1)	RS51973B (xx)
SI (1)	SI2029134T1 (xx)
TN (1)	TNSN08505A1 (xx)
TW (2)	TWI520735B (xx)
UY (1)	UY30394A1 (xx)
WO (1)	WO2007141298A1 (xx)
ZA (1)	ZA200806411B (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2294047A2 (en) *	2008-04-04	2011-03-16	Actavis Group PTC EHF	Novel mandelate salt of fesoterodine
IT1392082B1 (it) *	2008-12-10	2012-02-09	Chemi Spa	Nuove forme solide della fesoterodina fumarato
MX2011011937A (es)	2009-05-11	2012-01-27	Ratiopharm Gmbh	Desfesoterodina en la forma de una sal del acido tartarico.
EP2316432A1 (de)	2009-10-30	2011-05-04	ratiopharm GmbH	Zusammensetzung enthaltend Fesoterodin und Ballaststoffe
EP2549985A1 (en) *	2010-03-22	2013-01-30	Cadila Healthcare Limited	Stable pharmaceutical compositions comprising fesoterodine
TWI520732B (zh) *	2011-01-18	2016-02-11	輝瑞有限公司	固體分子分散液
EP2508173A1 (en)	2011-04-08	2012-10-10	LEK Pharmaceuticals d.d.	Stabilized pharmaceutical composition comprising fesoterodine
EP2508175A1 (en)	2011-04-08	2012-10-10	LEK Pharmaceuticals d.d.	Pharmaceutical composition comprising fesoterodine or a salt or a solvate thereof
WO2013054337A1 (en) *	2011-07-04	2013-04-18	Cadila Healthcare Limited	Extended release pharmaceutical compositions of fesoterodine
US9440910B2 (en) *	2012-05-18	2016-09-13	Alembic Pharmaceuticals Limited	Reference markers for fesoterodine fumarate
WO2014006636A2 (en) *	2012-07-02	2014-01-09	Hetero Research Foundation	Stable compositions of fesoterodine
HUE056810T2 (hu)	2012-11-02	2022-03-28	Murray & Poole Entpr Ltd	Szív- és érrendszeri események kezelése és megelõzése kolchicin alkalmazásával
HRP20210963T1 (hr) *	2013-04-16	2021-09-17	Murray & Poole Enterprises, Ltd.	Formulacija za kontinuirano otpuštanje kolhicina i postupci priprave istog
BR112015026418B1 (pt)	2013-04-16	2022-10-04	Murray And Poole Enterprises Limited	Formulação de liberação prolongada de colchicina e uso da referida formulação de liberação prolongada de colchicina
CZ2014400A3 (cs)	2014-06-09	2015-12-16	Zentiva, K.S.	Stabilizovaná formulace fesoterodinu
CN105687154A (zh) *	2014-11-27	2016-06-22	合肥信风科技开发有限公司	含非索罗定的药用组合物及其制备方法
WO2019011393A1 (en)	2017-07-12	2019-01-17	Rontis Hellas S.A.	EXTENDED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING FESOTERODINE AND PREPARATION METHOD THEREOF
TR201721437A2 (tr) *	2017-12-25	2019-07-22	Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi	Fesoterodi̇ni̇n modi̇fi̇ye salim sağlayan formülasyonlari
WO2019132832A1 (en) *	2017-12-25	2019-07-04	Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi	Tablet compositions of fesoterodine fumarate
KR102018495B1 (ko) *	2018-03-13	2019-09-05	충북대학교 산학협력단	과민성 방광의 치료를 위한 서방형의 이중층 정제 및 이의 제조방법
EP3784217A1 (en)	2018-04-26	2021-03-03	Rontis Hellas S.A.	Extended release pharmaceutical composition containing fesoterodine and process for the preparation thereof
CN110151720B (zh) *	2019-05-09	2019-12-17	合肥信风科技开发有限公司	含非索罗定的药用组合物及其制备方法
CN116234555A (zh) *	2020-06-30	2023-06-06	安布里亚制药公司	改良形式的曲美他嗪的改良释放制剂
WO2023145486A1 (ja) *	2022-01-28	2023-08-03	沢井製薬株式会社	フェソテロジンフマル酸塩含有製剤の製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20010034552A (ko) *	1998-03-03	2001-04-25	요시히코 시오노	포스포리파제 저해제인 소듐[[3-(2-아미노-1,2-디옥소에틸)-2-에틸-1-(페닐메틸)-1ｈ-인돌-4-일]옥시]아세테이트를 포함하는 약학적 조성물
EP0957073A1 (en) *	1998-05-12	1999-11-17	Schwarz Pharma Ag	Novel derivatives of 3,3-diphenylpropylamines
DE29923134U1 (de) *	1999-11-16	2000-06-29	Schwarz Pharma Ag, 40789 Monheim	Stabile Salze neuartiger Derviate von 3,3-Diphenylpropylaminen
DE10224107A1 (de)	2002-05-29	2003-12-11	Gruenenthal Gmbh	Kombination ausgewählter Opioide mit anderen Wirkstoffen zur Therapie der Harninkontinenz
DE10315878B4 (de)	2003-04-08	2009-06-04	Schwarz Pharma Ag	Vorrichtung zur transdermalen Verabreichung von Fesoterodin und Verwendung

2007
- 2007-06-06 PE PE2007000695A patent/PE20080331A1/es active IP Right Grant
- 2007-06-06 MX MX2008015736A patent/MX2008015736A/es active IP Right Grant
- 2007-06-06 EA EA200802444A patent/EA015909B9/ru active Protection Beyond IP Right Term
- 2007-06-06 PT PT07729956T patent/PT2029134E/pt unknown
- 2007-06-06 DK DK07729956.8T patent/DK2029134T3/da active
- 2007-06-06 AP AP2008004673A patent/AP2416A/xx active
- 2007-06-06 JP JP2009513691A patent/JP4743321B2/ja active Active
- 2007-06-06 CN CN2007800212925A patent/CN101466371B/zh not_active Expired - Fee Related
- 2007-06-06 TW TW102118368A patent/TWI520735B/zh not_active IP Right Cessation
- 2007-06-06 AT AT07729956T patent/ATE517619T1/de active
- 2007-06-06 MY MYPI20084409A patent/MY146574A/en unknown
- 2007-06-06 TW TW096120242A patent/TWI397409B/zh not_active IP Right Cessation
- 2007-06-06 UY UY30394A patent/UY30394A1/es active IP Right Grant
- 2007-06-06 BR BRPI0712865-7A patent/BRPI0712865B1/pt not_active IP Right Cessation
- 2007-06-06 PE PE2011001996A patent/PE20120476A1/es not_active Application Discontinuation
- 2007-06-06 KR KR1020087027920A patent/KR101316773B1/ko active Active
- 2007-06-06 WO PCT/EP2007/055582 patent/WO2007141298A1/en not_active Ceased
- 2007-06-06 HR HR20110776T patent/HRP20110776T1/hr unknown
- 2007-06-06 NZ NZ572616A patent/NZ572616A/en not_active IP Right Cessation
- 2007-06-06 ES ES07729956T patent/ES2370943T3/es active Active
- 2007-06-06 PL PL07729956T patent/PL2029134T3/pl unknown
- 2007-06-06 RS RS20110469A patent/RS51973B/sr unknown
- 2007-06-06 CA CA2652712A patent/CA2652712C/en active Active
- 2007-06-06 EP EP07729956A patent/EP2029134B1/en active Active
- 2007-06-06 AU AU2007255408A patent/AU2007255408B2/en not_active Ceased
- 2007-06-06 SI SI200730758T patent/SI2029134T1/sl unknown
- 2007-06-08 NL NL2000690A patent/NL2000690C2/nl active Search and Examination
- 2007-06-08 AR ARP070102485A patent/AR061289A1/es not_active Application Discontinuation
2008
- 2008-07-21 ZA ZA200806411A patent/ZA200806411B/xx unknown
- 2008-12-01 NI NI200800318A patent/NI200800318A/es unknown
- 2008-12-04 GT GT200800276A patent/GT200800276A/es unknown
- 2008-12-04 IL IL195732A patent/IL195732A/en not_active IP Right Cessation
- 2008-12-05 TN TNP2008000505A patent/TNSN08505A1/fr unknown
- 2008-12-08 MA MA31460A patent/MA30504B1/fr unknown
- 2008-12-08 CU CU2008000235A patent/CU23850B1/es active IP Right Grant
- 2008-12-11 CR CR10494A patent/CR10494A/es unknown
- 2008-12-24 EC EC2008009010A patent/ECSP089010A/es unknown
2009
- 2009-01-09 NO NO20090141A patent/NO341980B1/no unknown
2011
- 2011-02-28 JP JP2011041842A patent/JP4781489B2/ja active Active
- 2011-10-17 CY CY20111100983T patent/CY1111934T1/el unknown
2012
- 2012-07-05 IL IL220800A patent/IL220800A/en active IP Right Grant

Also Published As

Publication number	Publication date
KR101316773B1 (ko)	2013-10-15
BRPI0712865A2 (pt)	2012-12-18
ECSP089010A (es)	2009-01-30
TW201336491A (zh)	2013-09-16
NO341980B1 (no)	2018-03-05
CA2652712A1 (en)	2007-12-13
AU2007255408A1 (en)	2007-12-13
NL2000690A1 (nl)	2007-12-11
AR061289A1 (es)	2008-08-20
TWI520735B (zh)	2016-02-11
NI200800318A (es)	2011-01-12
NL2000690C2 (nl)	2008-04-01
DK2029134T3 (da)	2011-10-17
CU23850B1 (es)	2012-10-15
UY30394A1 (es)	2007-11-30
TNSN08505A1 (fr)	2010-04-14
TW200814992A (en)	2008-04-01
AU2007255408B2 (en)	2013-03-14
JP2011140498A (ja)	2011-07-21
HRP20110776T1 (hr)	2011-11-30
AP2416A (en)	2012-06-01
NO20090141L (no)	2009-01-09
RS51973B (sr)	2012-02-29
EA200802444A1 (ru)	2009-06-30
MY146574A (en)	2012-08-30
ES2370943T3 (es)	2011-12-23
GT200800276A (es)	2009-06-18
HK1128626A1 (en)	2009-11-06
MX2008015736A (es)	2009-01-09
CR10494A (es)	2009-01-19
KR20090026135A (ko)	2009-03-11
IL195732A0 (en)	2009-09-01
BRPI0712865B1 (pt)	2021-08-17
JP4781489B2 (ja)	2011-09-28
PL2029134T3 (pl)	2011-12-30
CN101466371A (zh)	2009-06-24
CN101466371B (zh)	2011-10-05
EA015909B1 (ru)	2011-12-30
EA015909B9 (ru)	2012-03-30
AP2008004673A0 (en)	2008-12-31
PE20120476A1 (es)	2012-04-20
CU20080235A7 (es)	2011-04-26
CY1111934T1 (el)	2015-11-04
IL195732A (en)	2013-09-30
JP2009539802A (ja)	2009-11-19
EP2029134B1 (en)	2011-07-27
JP4743321B2 (ja)	2011-08-10
TWI397409B (zh)	2013-06-01
SI2029134T1 (sl)	2012-01-31
NZ572616A (en)	2010-11-26
ATE517619T1 (de)	2011-08-15
CA2652712C (en)	2014-04-01
PE20080331A1 (es)	2008-06-19
PT2029134E (pt)	2011-11-02
EP2029134A1 (en)	2009-03-04
WO2007141298A1 (en)	2007-12-13
IL220800A (en)	2015-03-31
MA30504B1 (fr)	2009-06-01

Publication	Publication Date	Title
IL220800A (en)	2015-03-31	Stabilized Pharmaceutical Preparations Containing Passoterodine
LT3984528T (lt)	2023-08-10	Farmacinė kompozicija, apimanti nilotinibą
EP2001498A4 (en)	2013-01-23	PHARMACEUTICAL COMPOSITIONS
IL194176A0 (en)	2011-08-01	Pharmaceutical compositions
GB0713625D0 (en)	2007-08-22	Pharmaceutical compositions
PL2124556T3 (pl)	2015-02-27	Kompozycje farmaceutyczne
SI1984009T1 (sl)	2013-02-28	Farmacevtski sestavki z izboljĺ ano stabilnostjo
PL2005958T3 (pl)	2013-11-29	Kompozycja farmaceutyczna do stosowania zewnętrznego
EP2222313A4 (en)	2011-02-16	PHARMACEUTICAL COMPOSITIONS
IL193372A0 (en)	2009-09-22	Pharmaceutical composition comprising oseltamivir phosphate
GB0608724D0 (en)	2006-06-14	Novel Pharmaceutical Compositions
EP2146695A4 (en)	2010-05-19	PHARMACEUTICAL COMPOSITIONS
PL2002828T3 (pl)	2019-11-29	Stały preparat farmaceutyczny
GB0614586D0 (en)	2006-08-30	Pharmaceutical Formulation
GB0610322D0 (en)	2006-07-05	Novel pharmaceutical compositions
EP2124959A4 (en)	2011-09-14	PHARMACEUTICAL COMPOSITION
IL198160A0 (en)	2009-12-24	Pharmaceutical formulations
ZA200808030B (en)	2010-03-31	Pharmaceutical compositions
GB0622964D0 (en)	2006-12-27	Pharmaceutical compositions
GB0621623D0 (en)	2006-12-06	Pharmaceutical compositions
GB0611079D0 (en)	2006-07-12	Pharmaceutical compositions
HU0600938D0 (en)	2007-02-28	Pharmaceutical compositions
HU0600939D0 (en)	2007-02-28	Pharmaceutical compositions
GB0609941D0 (en)	2006-06-28	Pharmaceutical compositions
SI1948155T1 (sl)	2012-07-31	Farmacevtski sestavki ki obsegajo droksidopo